Translated: Mo Moneyhttps://www.israelvalley.com/2019/01/nouveau-fonds-israelien-technologies-medicales-vise-a-lever-150m-dici-2020/
CBG Asset Management, an investment company owned by British businessman Vincent Tchenguiz, is one of the company's partners.
ALIVE HealthTech Fund, a newly established Israeli venture capital fund, aims to raise $ 50 million in commitments by the end of the quarter and $ 150 million by the end of 2019, according to Ascher Shmulewitz, president of the Israeli cannabis company Therapix Biosciences Ltd. The fund seeks to invest in medical technology, he said. The founding partners committed $ 32 million to the fund.
The new fund is a joint venture of Shmulewitz. The Israeli health maintenance organization Maccabi Healthcare Services; Chain of Assuta Israeli Medical Centers; CBG Asset Management, a UK-based investment firm owned by businessman Vincent Tchenguiz; and Michel Habib, former associate partner of Israeli venture capital firm Agate Medical Investment, and representative of Tchengiz in Israel.
Maccabi and Assuta will provide the fund with access to clinical trials, medical databases and commercial pilot projects.
Shmulewitz and Habib will co-manage this fund, which intends to invest primarily in start-ups in the development phase in the fields of medical devices and software, digital health, personalized health care, nutrition-related technologies and medical cannabis. .
Source: israelValley & Calcalist